For the Inventor, By the Inventor

Enter assignee name

Raritan, NJ, United States of America

Ortho-Mcneil Pharmaceutical Corp.

USPTO Granted Patents = 363

CIPO Patents = 13

EPO Patents = 10

Trademarks = 1

Forward Citations = 3,197

Loading Chart...

Loading Chart...

446 inventors (with patents filed for the assignee):

Bruce E Maryanoff (29 out of 101 patents)

Allen B Reitz (22 out of 101 patents)

Carlos Plata-Salaman (17 out of 19 patents)

4. William V Murray (16 out of 49 patents)

5. Andrew Lawrence Darrow (16 out of 16 patents)

6. Jianmei Wei (15 out of 39 patents)

7. Michael Hawkins (15 out of 30 patents)

8. J Guy Breitenbucher (15 out of 41 patents)

9. Barbara A Pio (15 out of 48 patents)

10. James Patrick Edwards (15 out of 165 patents)

11. William Joel Hoekstra (15 out of 81 patents)

12. Michael Nicholas Greco (14 out of 45 patents)

13. Zhihua Sui (14 out of 108 patents)

14. Steven P Meduna (14 out of 31 patents)

15. Hui Cai (14 out of 21 patents)

Core Competencies:

Phosphonic Acid Compounds

Serine Protease Inhibitors

Melanocortin Receptor Modulators

Glucose Reabsorption Inhibitors

Cytotoxic T Lymphocytes

Integrin-Mediated Disorders

Vasopressin Antagonists

Peptidomimetics

Estrogen Receptor Modulators

Chymase Activity Determination

Heterocyclic Compounds

Thrombin Receptor Antagonists

363 patents: Sort by Forward Citations

1. 8609888 - Phosphonic acid compounds as inhibitors of serine proteases (2013-12-17),

2. 8501791 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators (2013-08-06),

3. 8497373 - Phosphonic acid compounds as inhibitors of serine proteases (2013-07-30),

4. 8304430 - Phosphonic acid compounds as inhibitors of serine proteases (2012-11-06),

5. 8278268 - Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators (2012-10-02),

6. 8247599 - Phosphonic acid compounds as inhibitors of serine proteases (2012-08-21),

7. 8212039 - Phosphonic acid compounds as inhibitors of serine proteases (2012-07-03),

8. 8207338 - Phosphonic acid compounds as inhibitors of serine proteases (2012-06-26),

9. 8198440 - Phosphonic acid compounds as inhibitors of serine proteases (2012-06-12),

10. 8183213 - Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators (2012-05-22),

11. 8178673 - Phosphonic acid compounds as inhibitors of serine proteases (2012-05-15),

12. 8133972 - IgE antigenic peptides (2012-03-13),

13. 8133728 - Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease (2012-03-13),

14. 8133726 - Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease (2012-03-13),

15. 8106236 - Triaryl compounds and derivates thereof (2012-01-31),

Ortho-McNeil Pharmaceutical Corp. is a subsidiary of Janssen Pharmaceuticals, Inc., which is a part of the Janssen Pharmaceutical Companies of Johnson & Johnson. They are focused on developing and commercializing innovative prescription medicines that have a positive impact on patients' lives. Ortho-McNeil Pharmaceutical Corp. operates in various therapeutic areas, including cardiovascular diseases, infectious diseases, neuroscience, gastroenterology, and more.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

363 Patents

#2 in Raritan, NJ

#68 in New Jersey

#1,212 in US

#2,454 in the World

Raritan, NJ, United States of America

Ortho-Mcneil Pharmaceutical Corp.

Forward Citations = 3,197

446 inventors:

Bruce E Maryanoff (29 out of 101 patents)

Allen B Reitz (22 out of 101 patents)

Carlos Plata-Salaman (17 out of 19 patents)

4. William V Murray (16 out of 49 patents)

5. Andrew Lawrence Darrow (16 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…